Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$468.72 USD
-3.79 (-0.80%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $469.19 +0.47 (0.10%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $4.09 | 0.41% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 16.10%. Look out for VRTX's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of $4.09 per share, reflecting a year-over-year increase of 5.14%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services